Main Aspects of Pharmaceutical Development of In situ Immunobiological Drugs for Intranasal Administration
Description
INTRODUCTION: The review presents the latest developments in the area of intranasal in situ delivery systems of immunobiological drugs (IBDs). Interest in intranasal administration for IBDs has increased significantly due to the COVID-19 pandemic
